Clinical Trial Update: An Observational Study in Patients With Breast Cancer and Bone Metastases Receiving Ibandronate (Bondronat)

View source ↗

Summary

An observational study update describing outcomes for breast cancer patients with bone metastases who are receiving ibandronate (Bondronat). The sponsor is Hoff…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bondronat (ibandronic acid)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Status: COMPLETED